Cargando…
Responses to docetaxel plus vinorelbine in metastatic breast cancer patients failing high-dose chemotherapy
British Journal of Cancer (2002) 86, 1017–1018. DOI: 10.1038/sj/bjc/6600164 www.bjcancer.com © 2002 Cancer Research UK
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2002
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364159/ https://www.ncbi.nlm.nih.gov/pubmed/11953839 http://dx.doi.org/10.1038/sj.bjc.6600164 |
| _version_ | 1782153883949203456 |
|---|---|
| author | Andres, R Mayordomo, J I Isla, D Marti, J L Escudero, P Filipovich, E Saenz, A Alvarez, I Polo, E Tres, A |
| author_facet | Andres, R Mayordomo, J I Isla, D Marti, J L Escudero, P Filipovich, E Saenz, A Alvarez, I Polo, E Tres, A |
| author_sort | Andres, R |
| collection | PubMed |
| description | British Journal of Cancer (2002) 86, 1017–1018. DOI: 10.1038/sj/bjc/6600164 www.bjcancer.com © 2002 Cancer Research UK |
| format | Text |
| id | pubmed-2364159 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2002 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-23641592009-09-10 Responses to docetaxel plus vinorelbine in metastatic breast cancer patients failing high-dose chemotherapy Andres, R Mayordomo, J I Isla, D Marti, J L Escudero, P Filipovich, E Saenz, A Alvarez, I Polo, E Tres, A Br J Cancer Letter to the Editor British Journal of Cancer (2002) 86, 1017–1018. DOI: 10.1038/sj/bjc/6600164 www.bjcancer.com © 2002 Cancer Research UK Nature Publishing Group 2002-03-18 /pmc/articles/PMC2364159/ /pubmed/11953839 http://dx.doi.org/10.1038/sj.bjc.6600164 Text en Copyright © 2002 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter to the Editor Andres, R Mayordomo, J I Isla, D Marti, J L Escudero, P Filipovich, E Saenz, A Alvarez, I Polo, E Tres, A Responses to docetaxel plus vinorelbine in metastatic breast cancer patients failing high-dose chemotherapy |
| title | Responses to docetaxel plus vinorelbine in metastatic breast cancer patients failing high-dose chemotherapy |
| title_full | Responses to docetaxel plus vinorelbine in metastatic breast cancer patients failing high-dose chemotherapy |
| title_fullStr | Responses to docetaxel plus vinorelbine in metastatic breast cancer patients failing high-dose chemotherapy |
| title_full_unstemmed | Responses to docetaxel plus vinorelbine in metastatic breast cancer patients failing high-dose chemotherapy |
| title_short | Responses to docetaxel plus vinorelbine in metastatic breast cancer patients failing high-dose chemotherapy |
| title_sort | responses to docetaxel plus vinorelbine in metastatic breast cancer patients failing high-dose chemotherapy |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364159/ https://www.ncbi.nlm.nih.gov/pubmed/11953839 http://dx.doi.org/10.1038/sj.bjc.6600164 |
| work_keys_str_mv | AT andresr responsestodocetaxelplusvinorelbineinmetastaticbreastcancerpatientsfailinghighdosechemotherapy AT mayordomoji responsestodocetaxelplusvinorelbineinmetastaticbreastcancerpatientsfailinghighdosechemotherapy AT islad responsestodocetaxelplusvinorelbineinmetastaticbreastcancerpatientsfailinghighdosechemotherapy AT martijl responsestodocetaxelplusvinorelbineinmetastaticbreastcancerpatientsfailinghighdosechemotherapy AT escuderop responsestodocetaxelplusvinorelbineinmetastaticbreastcancerpatientsfailinghighdosechemotherapy AT filipoviche responsestodocetaxelplusvinorelbineinmetastaticbreastcancerpatientsfailinghighdosechemotherapy AT saenza responsestodocetaxelplusvinorelbineinmetastaticbreastcancerpatientsfailinghighdosechemotherapy AT alvarezi responsestodocetaxelplusvinorelbineinmetastaticbreastcancerpatientsfailinghighdosechemotherapy AT poloe responsestodocetaxelplusvinorelbineinmetastaticbreastcancerpatientsfailinghighdosechemotherapy AT tresa responsestodocetaxelplusvinorelbineinmetastaticbreastcancerpatientsfailinghighdosechemotherapy |